{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:51:20Z","timestamp":1780116680323,"version":"3.54.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10620-011-1731-x","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T07:53:18Z","timestamp":1305186798000},"page":"3112-3121","source":"Crossref","is-referenced-by-count":19,"title":["Expanding Applications: The Potential Usage of 5-Aminosalicylic Acid in Diverticular Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Antonio","family":"Tursi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond E.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Streck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"1731_CR1","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1097\/01.mcg.0000212603.28595.5c","volume":"40","author":"ST Bogardus Jr","year":"2006","unstructured":"Bogardus ST Jr. What do we know about diverticular disease? A brief overview. J Clin Gastroenterol. 2006;40:S108\u2013S111.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-5089(21)00097-3","volume":"4","author":"TG Parks","year":"1975","unstructured":"Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1975;4:53\u201369.","journal-title":"Clin Gastroenterol"},{"key":"1731_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000099480","volume":"25","author":"G Comparato","year":"2007","unstructured":"Comparato G, Pilotto A, Franze A, Franceschi M, Di MF. Diverticular disease in the elderly. Dig Dis. 2007;25:151\u2013159.","journal-title":"Dig Dis"},{"key":"1731_CR4","unstructured":"National Digestive Diseases Information Clearinghouse (NDDIC). Digestive diseases in the United States: epidemiology and impact. 1994."},{"key":"1731_CR5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-9610(94)90098-1","volume":"167","author":"CW Konvolinka","year":"1994","unstructured":"Konvolinka CW. Acute diverticulitis under age forty. Am J Surg. 1994;167:562\u2013565.","journal-title":"Am J Surg"},{"key":"1731_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jemermed.2007.02.022","volume":"33","author":"CD Cole","year":"2007","unstructured":"Cole CD, Wolfson AB. Case series: diverticulitis in the young. J Emerg Med. 2007;33:363\u2013366.","journal-title":"J Emerg Med"},{"key":"1731_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0002-9610(05)81177-8","volume":"164","author":"PR Schauer","year":"1992","unstructured":"Schauer PR, Ramos R, Ghiatas AA, Sirinek KR. Virulent diverticular disease in young obese men. Am J Surg. 1992;164:443\u2013446.","journal-title":"Am J Surg"},{"key":"1731_CR8","first-page":"1632","volume":"48","author":"W Aldoori","year":"2002","unstructured":"Aldoori W, Ryan-Harshman M. Preventing diverticular disease. Review of recent evidence on high-fibre diets. Can Fam Physician. 2002;48:1632\u20131637.","journal-title":"Can Fam Physician"},{"key":"1731_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ajcn\/60.5.757","volume":"60","author":"WH Aldoori","year":"1994","unstructured":"Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Trichopoulos DV, Willett WC. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr. 1994;60:757\u2013764.","journal-title":"Am J Clin Nutr"},{"key":"1731_CR10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jn\/128.4.714","volume":"128","author":"WH Aldoori","year":"1998","unstructured":"Aldoori WH, Giovannucci EL, Rockett HR, Sampson L, Rimm EB, Willett WC. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr. 1998;128:714\u2013719.","journal-title":"J Nutr"},{"key":"1731_CR11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.mcg.0000124003.07433.ee","volume":"38","author":"MH Floch","year":"2004","unstructured":"Floch MH, Bina I. The natural history of diverticulitis: fact and theory. J Clin Gastroenterol. 2004;38:S2\u2013S7.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2036.2006.02805.x","volume":"23","author":"F Hjern","year":"2006","unstructured":"Hjern F, Johansson C, Mellgren A, Baxter NN, Hjern A. Diverticular disease and migration\u2014the influence of acculturation to a Western lifestyle on diverticular disease. Aliment Pharmacol Ther. 2006;23:797\u2013805.","journal-title":"Aliment Pharmacol Ther"},{"key":"1731_CR13","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/01.mcg.0000225503.59923.6c","volume":"40","author":"JR Korzenik","year":"2006","unstructured":"Korzenik JR. Case closed? Diverticulitis: epidemiology and fiber. J Clin Gastroenterol. 2006;40:S112\u2013S116.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR14","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3748\/wjg.v12.i20.3225","volume":"12","author":"MH Floch","year":"2006","unstructured":"Floch MH, White JA. Management of diverticular disease is changing. World J Gastroenterol. 2006;12:3225\u20133228.","journal-title":"World J Gastroenterol"},{"key":"1731_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/bega.2002.0328","volume":"16","author":"S Jun","year":"2002","unstructured":"Jun S, Stollman N. Epidemiology of diverticular disease. Best Pract Res Clin Gastroenterol. 2002;16:529\u2013542.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1731_CR16","first-page":"983","volume":"33","author":"M Steel","year":"2004","unstructured":"Steel M. Colonic diverticular disease. Aust Fam Physician. 2004;33:983\u2013986.","journal-title":"Aust Fam Physician"},{"key":"1731_CR17","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/j.1572-0241.1999.01501.x","volume":"94","author":"NH Stollman","year":"1999","unstructured":"Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:3110\u20133121.","journal-title":"Am J Gastroenterol"},{"key":"1731_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(04)15597-9","volume":"363","author":"N Stollman","year":"2004","unstructured":"Stollman N, Raskin JB. Diverticular disease of the colon. Lancet. 2004;363:631\u2013639.","journal-title":"Lancet"},{"key":"1731_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11938-007-0018-y","volume":"10","author":"A Ibele","year":"2007","unstructured":"Ibele A, Heise CP. Diverticular disease: update. Curr Treat Options Gastroenterol. 2007;10:248\u2013256.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"1731_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000089779","volume":"73","author":"A Parra-Blanco","year":"2006","unstructured":"Parra-Blanco A. Colonic diverticular disease: pathophysiology and clinical picture. Digestion. 2006;73:47\u201357.","journal-title":"Digestion"},{"key":"1731_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.dld.2004.03.001","volume":"36","author":"HN Aydin","year":"2004","unstructured":"Aydin HN, Remzi FH. Diverticulitis: when and how to operate? Dig Liver Dis. 2004;36:435\u2013445.","journal-title":"Dig Liver Dis"},{"key":"1731_CR22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0016-5085(19)35481-2","volume":"35","author":"RS Boles Jr","year":"1958","unstructured":"Boles RS Jr, Jordan SM. The clinical significance of diverticulosis. Gastroenterology. 1958;35:579\u2013582.","journal-title":"Gastroenterology"},{"key":"1731_CR23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10350-006-0578-2","volume":"49","author":"J Rafferty","year":"2006","unstructured":"Rafferty J, Shellito P, Hyman NH, Buie WD. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006;49:939\u2013944.","journal-title":"Dis Colon Rectum"},{"key":"1731_CR24","first-page":"1229","volume":"72","author":"H Salzman","year":"2005","unstructured":"Salzman H, Lillie D. Diverticular disease: diagnosis and treatment. Am Fam Physician. 2005;72:1229\u20131234.","journal-title":"Am Fam Physician"},{"key":"1731_CR25","first-page":"41","volume":"68","author":"U Haglund","year":"1979","unstructured":"Haglund U, Hellberg R, Johnsen C, Hulten L. Complicated diverticular disease of the sigmoid colon. An analysis of short and long term outcome in 392 patients. Ann Chir Gynaecol. 1979;68:41\u201346.","journal-title":"Ann Chir Gynaecol"},{"key":"1731_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bjs.4873","volume":"92","author":"S Janes","year":"2005","unstructured":"Janes S, Meagher A, Frizelle FA. Elective surgery after acute diverticulitis. Br J Surg. 2005;92:133\u2013142.","journal-title":"Br J Surg"},{"key":"1731_CR27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1572-0241.2003.07383.x","volume":"98","author":"S Ghorai","year":"2003","unstructured":"Ghorai S, Ulbright TM, Rex DK. Endoscopic findings of diverticular inflammation in colonoscopy patients without clinical acute diverticulitis: prevalence and endoscopic spectrum. Am J Gastroenterol. 2003;98:802\u2013806.","journal-title":"Am J Gastroenterol"},{"key":"1731_CR28","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1007\/s10620-007-0161-2","volume":"53","author":"A Tursi","year":"2008","unstructured":"Tursi A, Brandimarte G, Giorgetti G, Elisei W, Maiorano M, Aiello F. The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci. 2008;53:2474\u20132479.","journal-title":"Dig Dis Sci"},{"key":"1731_CR29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/MCG.0b013e3180653ca2","volume":"42","author":"A Tursi","year":"2008","unstructured":"Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699\u2013703.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR30","first-page":"269","volume-title":"Benign Colon: Diverticular Disease. The ASCRS Textbook of Colon and Rectal Surgery","author":"BG Wolff","year":"2010","unstructured":"Wolff BG, Fleshman JW, Beck DE. Benign Colon: Diverticular Disease. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer; 2010:269."},{"key":"1731_CR31","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1097\/01.mcg.0000225509.98041.4b","volume":"40","author":"F Di Mario","year":"2006","unstructured":"Di Mario F, Comparato G, Fanigliulo L, et al. Use of mesalazine in diverticular disease. J Clin Gastroenterol. 2006;40:S155\u2013S159.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","volume":"55","author":"L Dubuquoy","year":"2006","unstructured":"Dubuquoy L, Rousseaux C, Thuru X, et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut. 2006;55:1341\u20131349.","journal-title":"Gut"},{"key":"1731_CR33","doi-asserted-by":"crossref","unstructured":"Lewis JD, Lichtenstein GR, Deren JJ, et al. A randomized, placebo-controlled trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Gastroenterology. 2007;13:Abstract 639a.","DOI":"10.1053\/j.gastro.2007.04.017"},{"key":"1731_CR34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002689900401","volume":"22","author":"G Rogler","year":"1998","unstructured":"Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22:382\u2013389.","journal-title":"World J Surg"},{"key":"1731_CR35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1018876400528","volume":"42","author":"C Favier","year":"1997","unstructured":"Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn\u2019s disease. Dig Dis Sci. 1997;42:817\u2013822.","journal-title":"Dig Dis Sci"},{"key":"1731_CR36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/bega.2002.0297","volume":"16","author":"L Ludeman","year":"2002","unstructured":"Ludeman L, Warren BF, Shepherd NA. The pathology of diverticular disease. Best Pract Res Clin Gastroenterol. 2002;16:543\u2013562.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1731_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C Manichanh","year":"2006","unstructured":"Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach. Gut. 2006;55:205\u2013211.","journal-title":"Gut"},{"key":"1731_CR38","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/01.mcg.0000123993.13937.ec","volume":"38","author":"MA Peppercorn","year":"2004","unstructured":"Peppercorn MA. The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol. 2004;38:S8\u2013S10.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR39","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/01.mcg.0000225502.29498.ba","volume":"40","author":"MH Floch","year":"2006","unstructured":"Floch MH. A hypothesis is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol. 2006;40:S121\u2013S125.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02555508","volume":"27","author":"GE Sladen","year":"1984","unstructured":"Sladen GE, Filipe MI. Is segmental colitis a complication of diverticular disease? Dis Colon Rectum. 1984;27:513\u2013514.","journal-title":"Dis Colon Rectum"},{"key":"1731_CR41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/14656566.8.3.299","volume":"8","author":"A Tursi","year":"2007","unstructured":"Tursi A. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother. 2007;8:299\u2013307.","journal-title":"Expert Opin Pharmacother"},{"key":"1731_CR42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.332.7536.271","volume":"332","author":"SE Janes","year":"2006","unstructured":"Janes SE, Meagher A, Frizelle FA. Management of diverticulitis. BMJ. 2006;332:271\u2013275.","journal-title":"BMJ"},{"key":"1731_CR43","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","volume":"122","author":"RS Sandler","year":"2002","unstructured":"Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500\u20131511.","journal-title":"Gastroenterology"},{"key":"1731_CR44","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1572-0241.2006.00723.x","volume":"101","author":"NJ Shaheen","year":"2006","unstructured":"Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128\u20132138.","journal-title":"Am J Gastroenterol"},{"key":"1731_CR45","unstructured":"World Gastroenterology Organisation (WGO). Practice guidelines 2007: diverticular disease. Available at http:\/\/www.worldgastroenterology.org\/assets\/downloads\/en\/pdf\/guidelines\/07_diverticular_disease.pdf.2007 ; Accessed 10.02.2010."},{"key":"1731_CR46","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1440-1746.2007.05118.x","volume":"22","author":"G Peppas","year":"2007","unstructured":"Peppas G, Bliziotis IA, Oikonomaki D, Falagas ME. Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol. 2007;22:1360\u20131368.","journal-title":"J Gastroenterol Hepatol"},{"key":"1731_CR47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00365520600780650","volume":"42","author":"F Hjern","year":"2007","unstructured":"Hjern F, Josephson T, Altman D, et al. Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory? Scand J Gastroenterol. 2007;42:41\u201347.","journal-title":"Scand J Gastroenterol"},{"key":"1731_CR48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","volume":"201","author":"C Rousseaux","year":"2005","unstructured":"Rousseaux C, Lefebvre B, Dubuquoy L, et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med. 2005;201:1205\u20131215.","journal-title":"J Exp Med"},{"key":"1731_CR49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1172\/JCI110474","volume":"69","author":"WF Stenson","year":"1982","unstructured":"Stenson WF, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest. 1982;69:494\u2013497.","journal-title":"J Clin Invest"},{"key":"1731_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gut.32.1.50","volume":"32","author":"YR Mahida","year":"1991","unstructured":"Mahida YR, Lamming CE, Gallagher A, Hawthorne AB, Hawkey CJ. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut. 1991;32:50\u201354.","journal-title":"Gut"},{"key":"1731_CR51","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.33.7.929","volume":"33","author":"D Rachmilewitz","year":"1992","unstructured":"Rachmilewitz D, Karmeli F, Schwartz LW, Simon PL. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation. Gut. 1992;33:929\u2013932.","journal-title":"Gut"},{"key":"1731_CR52","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","volume":"116","author":"GC Kaiser","year":"1999","unstructured":"Kaiser GC, Yan F, Polk DB. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. Gastroenterology. 1999;116:602\u2013609.","journal-title":"Gastroenterology"},{"key":"1731_CR53","doi-asserted-by":"crossref","first-page":"26448","DOI":"10.1074\/jbc.274.37.26448","volume":"274","author":"LJ Egan","year":"1999","unstructured":"Egan LJ, Mays DC, Huntoon CJ, et al. Inhibition of interleukin-1-stimulated NF-kappaB RelA\/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem. 1999;274:26448\u201326453.","journal-title":"J Biol Chem"},{"key":"1731_CR54","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0016-5085(90)90329-Y","volume":"98","author":"I Ahnfelt-Ronne","year":"1990","unstructured":"Ahnfelt-Ronne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology. 1990;98:1162\u20131169.","journal-title":"Gastroenterology"},{"key":"1731_CR55","first-page":"245","volume":"45","author":"E Trepsi","year":"1999","unstructured":"Trepsi E, Colla C, Panizza P, et al. Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4\u00a0year follow-up results. Minerva Gastroenterol Dietol. 1999;45:245\u2013252.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"1731_CR56","first-page":"I70","volume":"10","author":"G Brandimarte","year":"2004","unstructured":"Brandimarte G, Tursi A. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit. 2004;10:I70\u2013I73.","journal-title":"Med Sci Monit"},{"key":"1731_CR57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10620-005-2478-z","volume":"50","author":"F Di Mario","year":"2005","unstructured":"Di Mario F, Aragona G, Leandro G, et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci. 2005;50:581\u2013586.","journal-title":"Dig Dis Sci"},{"key":"1731_CR58","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1007\/s10620-007-9766-8","volume":"52","author":"G Comparato","year":"2007","unstructured":"Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci. 2007;52:2934\u20132941.","journal-title":"Dig Dis Sci"},{"key":"1731_CR59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000103896","volume":"25","author":"G Comparato","year":"2007","unstructured":"Comparato G, Fanigliulo L, Aragona G, et al. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis. 2007;25:252\u2013259.","journal-title":"Dig Dis"},{"key":"1731_CR60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10620-006-9551-0","volume":"52","author":"A Tursi","year":"2007","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci. 2007;52:671\u2013674.","journal-title":"Dig Dis Sci"},{"key":"1731_CR61","unstructured":"Kruis W, Meier E, Schumacher M, et al. Treatment of painful diverticular disease of the colon with mesalamine: a placebo-controlled study. Gastroenterology. 2007;132:A-191-Abstract S1187."},{"key":"1731_CR62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2036.2006.02809.x","volume":"23","author":"SV Kane","year":"2006","unstructured":"Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006;23:577\u2013585.","journal-title":"Aliment Pharmacol Ther"},{"key":"1731_CR63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2036.2003.01648.x","volume":"18","author":"MJ Shale","year":"2003","unstructured":"Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:191\u2013198.","journal-title":"Aliment Pharmacol Ther"},{"key":"1731_CR64","unstructured":"Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis (NCT00695643). Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00695643 ; Accessed 2.02.2010."},{"key":"1731_CR65","unstructured":"Prevention of Recurrence of Diverticulitis (PREVENT 1) (NCT00545740). Available at http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00545740 ; Accessed 2.02.2010."},{"key":"1731_CR66","unstructured":"Prevention of Recurrence of Diverticulitis (PREVENT 2) (NCT00545103). Available at http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00545103 ; Accessed 2.02.2010."},{"key":"1731_CR67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","volume":"34","author":"A Tursi","year":"2002","unstructured":"Tursi A, Brandimarte G, Daffina R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002;34:510\u2013515.","journal-title":"Dig Liver Dis"},{"key":"1731_CR68","doi-asserted-by":"crossref","first-page":"F186","DOI":"10.1136\/fn.83.3.F186","volume":"83","author":"MM Gronlund","year":"2000","unstructured":"Gronlund MM, Arvilommi H, Kero P, Lehtonen OP, Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0\u20136\u00a0months. Arch Dis Child Fetal Neonatal Ed. 2000;83:F186\u2013F192.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1731_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2001.tb00526.x","volume":"32","author":"PV Kirjavainen","year":"2001","unstructured":"Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol. 2001;32:1\u20137.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1731_CR70","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/MMBR.62.4.1157-1170.1998","volume":"62","author":"PG Falk","year":"1998","unstructured":"Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev. 1998;62:1157\u20131170.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1731_CR71","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.3748\/wjg.v11.i18.2773","volume":"11","author":"A Tursi","year":"2005","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol. 2005;11:2773\u20132776.","journal-title":"World J Gastroenterol"},{"key":"1731_CR72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-1605(97)00136-0","volume":"39","author":"F Guarner","year":"1998","unstructured":"Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39:237\u2013238.","journal-title":"Int J Food Microbiol"},{"key":"1731_CR73","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2006.02896.x","volume":"23","author":"L Petruzziello","year":"2006","unstructured":"Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G. Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther. 2006;23:1379\u20131391.","journal-title":"Aliment Pharmacol Ther"},{"key":"1731_CR74","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S1590-8658(02)80166-9","volume":"34","author":"P Gionchetti","year":"2002","unstructured":"Gionchetti P, Amadini C, Rizzello F, et al. Probiotics\u2014role in inflammatory bowel disease. Dig Liver Dis. 2002;34:S58\u2013S62.","journal-title":"Dig Liver Dis"},{"key":"1731_CR75","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11894-007-0055-7","volume":"9","author":"EM Quigley","year":"2007","unstructured":"Quigley EM. Probiotics in the management of colonic disorders. Curr Gastroenterol Rep. 2007;9:434\u2013440.","journal-title":"Curr Gastroenterol Rep"},{"key":"1731_CR76","first-page":"66","volume":"53","author":"ME Sanders","year":"1999","unstructured":"Sanders ME. Probiotics. Food Technol. 1999;53:66\u201377.","journal-title":"Food Technol"},{"key":"1731_CR77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00042737-200303000-00015","volume":"15","author":"P Fric","year":"2003","unstructured":"Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol. 2003;15:313\u2013315.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1731_CR78","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.mcg.0000210092.77296.6d","volume":"40","author":"A Tursi","year":"2006","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Mesalazine and\/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol. 2006;40:312\u2013316.","journal-title":"J Clin Gastroenterol"},{"key":"1731_CR79","first-page":"916","volume":"55","author":"A Tursi","year":"2008","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Mesalazine and\/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon. Hepatogastroenterology. 2008;55:916\u2013920.","journal-title":"Hepatogastroenterology"},{"key":"1731_CR80","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00384-007-0299-6","volume":"22","author":"A Tursi","year":"2007","unstructured":"Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Aiello F. Balsalazide and\/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis. 2007;22:1103\u20131108.","journal-title":"Int J Colorectal Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1731-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1731-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T03:59:56Z","timestamp":1637639996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1731-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]}}}